KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $136.6 million.

  • Biogen's Amortization - Intangibles fell 965.61% to $136.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $515.0 million, marking a year-over-year increase of 1528.99%. This contributed to the annual value of $515.0 million for FY2025, which is 1528.99% up from last year.
  • Biogen's Amortization - Intangibles amounted to $136.6 million in Q4 2025, which was down 965.61% from $135.7 million recorded in Q3 2025.
  • Biogen's 5-year Amortization - Intangibles high stood at $604.1 million for Q2 2021, and its period low was $50.2 million during Q1 2023.
  • Over the past 5 years, Biogen's median Amortization - Intangibles value was $92.5 million (recorded in 2021), while the average stood at $122.5 million.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first skyrocketed by 88227.64% in 2021, then tumbled by 8882.64% in 2022.
  • Biogen's Amortization - Intangibles (Quarter) stood at $68.1 million in 2021, then surged by 156.98% to $175.0 million in 2022, then plummeted by 56.23% to $76.6 million in 2023, then surged by 97.39% to $151.2 million in 2024, then decreased by 9.66% to $136.6 million in 2025.
  • Its Amortization - Intangibles was $136.6 million in Q4 2025, compared to $135.7 million in Q3 2025 and $130.9 million in Q2 2025.